Now Available! | Check out UMR’s 2024 Annual Economic Report and State Toolkits today
NIH Research 101 | UMR Answers Common Questions About NIH Research in this New Fact Sheet Series
Rural State Analysis | UMR's 2023 Report Reveals the Exponential Impact of NIH Research Funding in 7 Rural States
Why Invest in NIH Research? | UMR Offers Fact Sheets Explaining Why Congress Must #keepNIHstrong
Privacy Policy © 2024 United For Medical Research. All Rights Reserved.

A participant in the NIH 2019-2020 Medical Research Scholars Program.

Photo Credit: National Institutes of Health

About This Photo

Thermo Fisher Scientific Response to COVID-19 Expands to Include New Serology Test in Collaboration with WuXi Diagnostics and Mayo Clinic

Thermo Fisher Scientific Response to COVID-19 Expands to Include New Serology Test in Collaboration with WuXi Diagnostics and Mayo Clinic

By

“Rapidly expanding access to high-quality testing requires bold collaborations across the laboratory industry. This marks a significant milestone in our national testing response to COVID-19 and was made possible by bringing together the commercialization capabilities of Thermo Fisher Scientific, testing development abilities of WuXi Diagnostics, and clinical and laboratory expertise of Mayo Clinic physicians and … Continued

Thermo Fisher Scientific Announces SARS-CoV-2 GlobalAccess Sequencing Program

By

To accelerate national, multi-institutional efforts focused on mapping coronavirus transmission and epidemiological studies, Thermo Fisher Scientific today announces the SARS-CoV-2 GlobalAccess Sequencing Program for research consortia and industry groups battling the spread of the pandemic globally. Under the program, the company will provide 50 units of the Ion Torrent Genexus System at a subsidized price … Continued

Thermo Fisher Scientific commits to rapidly expanding testing capacity from 5 to 10 million tests per week

By

At a White House Coronavirus Task Force briefing held Monday, April 27, Thermo Fisher Scientific CEO Marc Casper announced the company’s plans to rapidly expanding testing capacity from 5 to 10 million tests per week by mid to late May.

“Science with a Twist” Podcast: Fighting Coronavirus: Confirming and Containing an Outbreak

By

As the Coronavirus continues to spread, doctors, scientists and health agencies are racing to contain the outbreak. In this episode of Thermo Fisher‘s Science with a Twist podcast, hear how they are using scientific technologies to detect, prevent and develop a vaccine for this respiratory syndrome.

Ford partners with Thermo Fisher on COVID-19 collection kits, expands production to face masks, gowns

By

Ford has expanded its plan to produce critical medical equipment and supplies, including a new effort to make reusable gowns from airbag materials as well as a partnership with scientific instrument provider Thermo Fisher Scientific to ramp up production of COVID-19 collection kits to test for the virus. This broader plan highlights the latest effort … Continued

CRISPR pioneer Doudna opens lab to run COVID-19 tests

By

The new lab is housed at the University of California, Berkeley’s Innovative Genomics Institute, where Doudna is the executive director. It is being run by more than 50 volunteers from Berkeley and its environs, including the chief scientific officer of lab equipment giant Thermo Fisher, team members from Salesforce, the head of commercial at laboratory … Continued

Shortages of face masks, swabs and basic supplies pose a new challenge to coronavirus testing

By

CDC tells health-care workers to use bandannas if they don’t have face masks Firms such as Roche and Thermo Fisher Scientific have been working to send new testing platforms approved by the FDA to major labs. Once those are up and running, testing capacity should greatly increase. But that change won’t happen overnight.

Massachusetts life-sciences industry at forefront of worldwide fight against coronavirus

By

Companies like Alnylam, Moderna, and Thermo Fisher are mobilizing As Massachusetts braces for a surge of patients infected with the coronavirus, the state is playing an outsize role in the global fight against the pandemic. Companies in the state are scrambling to develop and distribute potential vaccines, drugs, and diagnostic tests.

Coronavirus has ‘stable genome,’ study suggests, so vaccine could help ‘over many years’

By

Currently, there is no known specific medicine to treat the novel coronavirus, but researchers in Italy suggest that the COVID-19 disease is slow to mutate, based on its genetic material. The study, which was produced by two independent teams in the country, used “a new next-generation sequencing (NGS) research assay” from Thermo Fisher Scientific on Italian … Continued